Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$2.21 - $3.22 $5.98 Million - $8.72 Million
-2,707,463 Reduced 4.92%
52,335,002 $122 Million
Q2 2020

Aug 14, 2020

BUY
$0.87 - $3.13 $7.91 Million - $28.5 Million
9,090,909 Added 19.78%
55,042,465 $171 Million
Q3 2019

Nov 14, 2019

BUY
$0.47 - $1.05 $9.4 Million - $21 Million
20,000,000 Added 77.07%
45,951,556 $46 Million
Q2 2019

Aug 14, 2019

BUY
$0.65 - $2.12 $1.3 Million - $4.24 Million
2,000,000 Added 8.35%
25,951,556 $24.6 Million
Q4 2018

Feb 14, 2019

BUY
$1.22 - $2.41 $17.4 Million - $34.4 Million
14,285,713 Added 147.8%
23,951,556 $38.3 Million
Q4 2017

Feb 14, 2018

BUY
$3.29 - $5.03 $10.2 Million - $15.6 Million
3,100,000 Added 47.21%
9,665,843 $41.3 Million
Q3 2017

Nov 14, 2017

BUY
$3.15 - $4.01 $20.7 Million - $26.3 Million
6,565,843
6,565,843 $25.3 Million

Others Institutions Holding VBIV

About VBI Vaccines Inc


  • Ticker VBIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 258,256,992
  • Market Cap $5.17M
  • Description
  • VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...
More about VBIV
Track This Portfolio

Track Perceptive Advisors LLC Portfolio

Follow Perceptive Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.